LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the U.S. of Glycopyrrolate Injection, USP in 0.6 mg per 3 mL Simplist ® ready-to-administer prefilled ...
LONDON, Oct 9 (Reuters) - Contract drug manufacturers seeking to tap into the booming market for weight-loss drugs are investing billions of dollars to expand or build factories that fill the ...
The Simplist ready-to-administer prefilled syringes minimize preparation steps for clinicians. Fresenius Kabi has announced the launch of Glycopyrrolate Injection, USP 0.6mg per 3mL in the Simplist ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback